Clinical Trial Update: Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Gentian Violet with Nystatin oral suspension for treating oropharyngeal candidiasis in HIV-1 infected individuals completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Oropharyngeal Candidiasis

Drugs mentioned

• Gentian Violet (gentian violet)
• Nystatin oral suspension (Nystatin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2015-02-16